MYH13: A Potential Therapeutic Target for Muscle-Related Conditions

Target Name: MYH13

NCBI ID: G8735

MYH13

MYH13: A Potential Therapeutic Target for Muscle-Related Conditions

Myosin heavy chain (MYH13) is a protein that plays a critical role in the structure and function of skeletal muscles. It is a key component of the myosin filament, which is the protein that powers the muscle contractions that allow us to move and maintain our posture.MYH13 is a 13-kDa protein that is expressed in high levels in skeletal muscles and is involved in the regulation of muscle contractions.

MYH13 is a drug target (or biomarker) that has been identified as a potential therapeutic target for a variety of muscle-related conditions, including muscle weakness, muscle fatigue, and muscle damage.

The Importance of MYH13

MYH13 is a key regulator of muscle contractions. It plays a critical role in the regulation of muscle force production and in the maintenance of muscle contractions during rest.MYH13 helps to ensure that muscle cells are able to generate the necessary amount of force to support our movements and maintain our posture.

MYH13 is also involved in the regulation of muscle fatigue and muscle damage. It helps to protect muscle cells from fatigue and damage, and it plays a key role in the regulation of muscle repair.

The Potential Therapeutic Benefits of MYH13

MYH13 has the potential to be a therapeutic target for a variety of muscle-related conditions, including muscle weakness, muscle fatigue, and muscle damage.

One of the key benefits of MYH13 is its ability to modulate muscle contractions.MYH13 has been shown to play a critical role in the regulation of muscle force production and in the maintenance of muscle contractions during rest. By modulating muscle contractions, MYH13 can help to ensure that muscle cells are able to generate the necessary amount of force to support our movements and maintain our posture.

MYH13 may also be a useful biomarker for muscle-related conditions. The levels of MYH13 have been shown to be elevated in muscle-related tissues, including muscle biopsies and muscle samples. This may be an indication that MYH13 is a useful diagnostic tool for muscle-related conditions.

TheMYH13 gene is located on chromosome X and has been shown to encode a protein with 13 kDa of molecular mass. It is a single gene gene and has been identified as a potential therapeutic target for a variety of muscle-related conditions.

Conclusion

MYH13 is a protein that plays a critical role in the structure and function of skeletal muscles. It is a key component of the myosin filament and is involved in the regulation of muscle contractions, muscle fatigue, and muscle damage.MYH13 has the potential to be a therapeutic target for a variety of muscle-related conditions, including muscle weakness, muscle fatigue, and muscle damage. Further research is needed to fully understand the role of MYH13 in muscle physiology and to develop effective therapies for these conditions.

Protein Name: Myosin Heavy Chain 13

Functions: Fast twitching myosin mediating the high-velocity and low-tension contractions of specific striated muscles

The "MYH13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYH13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets